Literature DB >> 6102511

Inhibition by propranolol of 3,5,3'-triiodothyronine formation from thyroxine in isolated rat renal tubules: an effect independent of beta-adrenergic blockade.

P Heyma, R G Larkins, D G Campbell.   

Abstract

Recent studies in man have shown a decrease in serum L-T3 (T3) levels in subjects treated with DL-propranolol, but the mechanism of this effect is unknown. Isolated rat renal tubules were used to study the effect of propranolol and related drugs on the formation of T3 from L-T4 (T4). Racemic (DL) propranolol at 100 microM inhibited the net formation of T3 from T4 by 35% (P less than 0.01). The D- and L-isomers of propranolol were also potent in inhibiting T3 formation, but the beta-blockers atenolol and sotalol, which have no significant membrane-stabilizing activity, had no effect at similar concentrations. Quinidine inhibited T3 formation, with a dose-response curve which was similar over the concentrations studied to that of DL-propranolol. L-Epinephrine and L-isoproterenol had no effect on T3 formation, and equimolar amounts of L-isoproterenol did not prevent the inhibition of T3 formation by DL-propranolol. cAMP production was stimulated by 200 micro M L-isoproterenol, and this was blocked by an equimolar concentration of DL-propranolol but not of D-propranolol. It is concluded that DL-propranolol directly inhibits net T3 formation from T4 in this system by a direct membrane-stabilizing or quinidine-like action and not by specific beta-blockade.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102511     DOI: 10.1210/endo-106-5-1437

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  6 in total

1.  Effect of adrenaline on biliary excretion of triiodothyronines in rats mediated by alpha 1-adrenoceptors and related to the inhibition of 5'-monodeiodination in liver.

Authors:  P Langer; O Földes
Journal:  J Endocrinol Invest       Date:  1988 Jul-Aug       Impact factor: 4.256

2.  Influence of lipid solubility on the sperm immobilizing effect of beta-adrenoceptor blocking drugs.

Authors:  C Y Hong; P Turner
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 3.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

4.  Changes in blood chemistry in hypertensive patients during propranolol therapy.

Authors:  F Andreasen; P Jakobsen; H J Kornerup; E B Pedersen; O L Pedersen; J Weeke
Journal:  Br J Clin Pharmacol       Date:  1984-03       Impact factor: 4.335

5.  Acute effect of atenolol on serum thyroid hormones in hyperthyroid patients.

Authors:  S Rassu; A Masala; S Alagna; P P Rovasio; M Langer
Journal:  J Endocrinol Invest       Date:  1982 Jan-Feb       Impact factor: 4.256

6.  Factors altering thyroid hormone metabolism.

Authors:  J Robbins
Journal:  Environ Health Perspect       Date:  1981-04       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.